|
Covid Antiviral Pills Seen Surging After Slow Initial Uptake April 22, 2022, 7:40 AM
- Pfizer’s pill to sell close to $24 billion in 2022: Airfinity
- Data firm forecasts $32.5 billion in annual antiviral sales
Demand for Covid pills is set to make Pfizer Inc.’s Paxlovid among the fastest-selling treatments of all time, with revenue of almost $24 billion expected in 2022, according to a forecast from analytics group Airfinity Ltd. Overall sales of Covid pills are expected to hit $32.5 billion this year, up from a previous estimate of $19.5 billion, London-based Airfinity said Friday. Sales of pills from Merck & Co. and Shionogi & Co. are also set to rise as cases increase and earlier treatments are rendered ineffective by new variants. After slow initial uptake, demand for the pills is expected ...
| 
发表于 2022-4-24 06:34:51
楼主